Global Vascular Stent Market – Industry Trends and Forecast to 2029

Market Analysis and Size

Peripheral Arterial Disease (PAD) is the most common type of vascular disease, characterised by the buildup of plaque in the arteries that transport blood from the heart to the rest of the body. Atherosclerosis is the most common cause of PAD worldwide. Smoking, high blood pressure, diabetes, and high cholesterol are all risk factors for PAD. The lower extremity is the most common location for Peripheral Arterial Disease. The diagnosis and treatment of PAD differ from person to person. PAD can be treated surgically or with minimally invasive procedures. The most common and widely accepted form of treatment for PAD is the use of vascular stents.

Data Bridge Market Research analyses that the vascular stent market is expected to reach the value of USD 13.44 billion by the year 2029, at a CAGR of 7.81% during the forecast period.

Market Definition

Vascular stents are expandable mesh tubes made of medical grade stainless steel or cobalt alloy metal that are inserted into blocked arteries and veins to control blood flow. These are particularly useful in reducing recurrent artery and vein blockage and narrowing following angioplasty. When stents are implanted in an artery or vein, they remain there indefinitely, greatly reducing the risk of narrowing reoccurring.

Report scope and market segmentation

Vascular stent Market Dynamics

Drivers

• The increased demand for non-invasive surgical procedures

The growing global geriatric population, combined with an increase in demand for non-invasive surgical procedures, is broadening the scope of growth for the vascular stent market. Smoking, drinking alcohol, and eating unhealthy foods all contribute to the clogging or blocking of blood vessels

Low manufacturing costs

In the long run, this will increase demand for vascular stents. Other factors driving the growth of this market include a low risk-to-reward ratio and low manufacturing costs.

Regulatory Compliance

Maintaining compliance with medical reforms and diagnostics raises the demand for these solutions.

• Government investments for healthcare interoperability

The increase in the funding by the federal government to drive the adoption of these solutions further influence the market. Additionally, the surge in healthcare expenditure, advancements in healthcare infrastructure, and high demand for expanded care delivery positively affect the vascular stent market.

Opportunities

The strong trend of R&D investments in the biotechnology and pharmaceutical industries is also boosting market growth. Furthermore, rising per capita disposable income is one of the key factors fueling the growth of the vascular stent market.

Restraints/Challenges

However, stringent regulations imposed by the government to ensure patient safety will act as a significant market growth restraint. Furthermore, the high cost of undergoing the procedure will slow the market's growth rate even further.

This vascular stent market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the vascular stent market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Vascular Stent Market

Over the last 18 months, almost every industry in the world has suffered a setback. This is due to significant disruptions in their respective manufacturing and supply-chain operations as a result of various precautionary lockdowns and other restrictions imposed by governing authorities around the world. The same can be said about the global Vascular Stent market. Furthermore, consumer demand has subsequently decreased as people are now more focused on eliminating non-essential expenses from their respective budgets as the general economic status of most people has been severely impacted by this outbreak. These factors are expected to weigh on the revenue trajectory of the global Vascular Stent market over the forecast period.

.Recent Development

• Medtronic's dominant position in the total bare-metal stent market stems from its strong presence in the market's high-value iliac and femoral-popliteal segments.
• With its VIABAHN® portfolio, W. L. Gore controls a sizable portion of the high-value covered stent segment. VIABAHN® devices are priced slightly higher than other covered stents on the market, such as iCast® and Fluency®.
• With its Express® LD iliac stent and Express® SD stents, Boston Scientific is a major player in the iliac and renal stent segments.

Global Vascular Stent Market Scope

The vascular stent market is segmented on the basis of type, product, mode of delivery, materials and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type                                                                                

• Drug-eluting stents
• Bare-metal stents
• Bio absorbable stents

On the basis of type, the global vascular stent market is segmented into drug-eluting stents, bare-metal stents and bio absorbable stents.

Product

• Coronary stents
• Peripheral stents
• Evar stent grafts

On the basis of product, the vascular stent market is segmented into coronary stents, peripheral stents and evar stent grafts. Peripheral stents are further bifurcated into carotid artery stents, renal artery stents, femoral artery stents, and iliac artery stents. Evar stent grafts are also further sub-segmented into abdominal aortic aneurysm stents and thoracic aortic aneurysm stents.

Mode of delivery

• Balloon-expandable stents
• Self-expanding stents

The vascular stent market can also be segmented on the basis of mode of delivery into balloon-expandable stents and self-expanding stents.

Materials

• Metallic stunts
• Other stunts

The vascular stent market is segmented on the basis of materials into metallic stents and other stents. Metallic stents are further bifurcated into cobalt chromium, platinum chromium, nickel titanium and stainless steel.

End User

• Hospitals and cardiac centres
• Ambulatory surgical centres
• Others

On the basis of end users, the vascular stent market is segmented into hospitals and cardiac centres, ambulatory surgical centres and others.

Vascular Stent Market Regional Analysis/Insights

The vascular stent market is analysed and market size insights and trends are provided by country, type, product, mode of delivery, materials and end user referenced above.

The countries covered in the vascular stent market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America has dominated the market and will continue to do so during the forecast period due to the rapid increase in the adoption of minimal or non-invasive surgical procedures. Furthermore, the rapid advancement of technology is fueling this region's market share in the global vascular stent market. In contrast, Asia-Pacific is expected to grow at the fastest rate during the forecast period. The primary growth driver in this region is the growing geriatric population in need of medical care.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure growth Installed base and New Technology Penetration

The vascular stent market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for vascular stent market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the vascular stent market. The data is available for historic period 2010-2020.

Competitive Landscape and Vascular Stent Market Share Analysis

The vascular stent market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to vascular stent market.

Some of the major players operating in the vascular stent market are

• Medtronic (Ireland)
• BD. (US)
• Cordis. (US)
• Abbott. (US)
• Boston Scientific Corporation (US)
• Cook (UK,
• Cardiovascular Systems, Inc. (US)
• AngioDynamics. (US)
• Edwards Lifesciences Corporation. (US)
• Biosensors International Group, Ltd. (Singapore)
• W. L. Gore & Associates, Inc. (US)
• Teleflex Incorporated. (US)
• OrbusNeich Medical Company Limited (Hong Kong)
• Merit Medical Systems. (US)
• Terumo Medical Corporation (Japan)
• B. Braun Melsungen AG (Germany)
• MicroPort Scientific Corporation (China)
• Lepu Medical Technology (Beijing)Co.,Ltd (China)
• Koninklijke Philips N.V. (Netherlands)

.

---

SKU-10106